期刊： ACTA HAEMATOLOGICA, 2022; 145 (1)
Introduction: Patient blood management (PBM) is a clinical and multidisciplinary, 3-pillar concept. The aim of this study was to detect the subjective......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (2)
Background: BCR/ABL1-like acute lymphoblastic leukemia is a newly recognized high-risk subtype of ALL, characterized by the presence of genetic altera......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (1)
The co-occurrence of thymoma and T-lymphoblastic lymphoma/leukemia is an extremely rare but previously reported association that poses a diagnostic an......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (6)
Progressive multifocal leukoencephalopathy (PML) is a rare neurological disease caused by the reactivation of latent John Cunningham polyomavirus. Hem......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (6)
Introduction: Data regarding the prevalence of paraproteinemia in patients with chronic myeloid leukemia (CML) are lacking.Methods: To evaluate for pa......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (1)
Neurolymphomatosis (NL) is a rare condition caused by the lymphomatous or leukemic infiltration of nerves and manifests as neuropathy. Most often, NL ......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (1)
Sickle cell disease is characterized by vaso-occlusive phenomena and haemolytic anaemia. There is a significant concern that the overlap of COVID-19 l......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (1)
Introduction: Therapy of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with drugs such as ibrutinib and rituximab is often associa......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (2)
Introduction: Cord blood (CB) is becoming a valuable source for stem cells utilized in a variety of cell therapy applications, as well as for newborn ......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (3)
Coronavirus disease 2019 (COVID-19) has emerged as a pandemic at the end of 2019 and continues to exert an unfavorable worldwide health impact on a la......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (4)
Background: The use of unmanipulated haploidentical hematopoietic stem cell transplantations (haplo-HSCT) with post-transplant cyclophosphamide (PTCY)......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (6)
Introduction: Chromosomal abnormalities (CAs) have been identified as important factors in determining the biological features and prognostic value of......
期刊： ACTA HAEMATOLOGICA, 2022; 145 (6)
Hereditary spherocytosis (HS) is a congenital disease in which erythrocyte membranes are abnormal, with ANK1 defects as the main cause. The diagnosis ......
